Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01922297 · ClinicalTrials.gov registry record · NA

Juvenile Offender HIV Prevention and Drug Abuse Services

A NA study of Substance Abuse and Risk Behavior, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
121
Enrollment target
1
Study location

NCT01922297 is a NA study of Substance Abuse and Risk Behavior that has completed, run by University of Miami. The registered enrollment target is 121 participants, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01922297, a NA study of Substance Abuse and Risk Behavior, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target
1
Study location

Study Summary

This study will determine the clinical effectiveness, moderators and mechanisms of change, and economic impact of an integrative, family-based intervention that concurrently targets change in HIV/Sexually Transmitted Disease (STD)-associated risk behaviors, drug abuse, delinquency, arrest and mental health outcomes for juvenile offenders committed to a juvenile justice day treatment program.

Interventions

  • OTHER Day Treatment MDFT-HIV
  • OTHER Day Treatment SAU

Study Locations (1)

Florida

  • University of Miami Miller School of Medicine - Miami

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2010-01
Est. Completion 2015-04
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT01922297

The ClinicalTrials.gov registry entry for NCT01922297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Day Treatment MDFT-HIV is the first listed.

NCT01922297 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01922297 about?

NCT01922297 is a clinical study titled "Juvenile Offender HIV Prevention and Drug Abuse Services". This study will determine the clinical effectiveness, moderators and mechanisms of change, and economic impact of an integrative, family-based intervention that concurrently targets change in HIV/Sexually Transmitted Disease (STD)-associated risk behaviors, drug abuse, delinquency, arrest and mental...

What is the current status of trial NCT01922297?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2010-01. Estimated completion is 2015-04.

What conditions does trial NCT01922297 study?

This clinical trial studies the following conditions: Substance Abuse, Risk Behavior, Delinquency.

What interventions are being tested in trial NCT01922297?

The interventions under investigation include: Day Treatment MDFT-HIV (OTHER), Day Treatment SAU (OTHER).

Who is sponsoring clinical trial NCT01922297?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01922297 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.